Bayer

Bayer, Now Facing Headwinds, Has A History Of Bold Innovation
Bayer, Now Facing Headwinds, Has A History Of Bold Innovation
Forbes
Bayer
innovation
Flag link:
Bayer's trial flop, courtroom setback could restrict CEO's options amid strategic review: analyst
Bayer's trial flop, courtroom setback could restrict CEO's options amid strategic review: analyst
Fierce Pharma
Bayer
Pharma CEOs
Bill Anderson
asundexian
Flag link:
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast
Fierce Biotech
Bayer
asundexian
bloodthinners
Eliquis
clinical trials
Flag link:
J&J and Bayer's Xarelto proves its worth across PAD subgroups in 2 new analyses
J&J and Bayer's Xarelto proves its worth across PAD subgroups in 2 new analyses
Fierce Pharma
JNJ
Bayer
Xarelto
blood thinners
AHA
peripheral artery disease
Flag link:
Bayer to withdraw follicular lymphoma therapy after trial failure
Bayer to withdraw follicular lymphoma therapy after trial failure
Clinical Trials Arena
Bayer
Aliqopa
relapsed follicular lymphoma
clinical trials
Flag link:
European regulator endorses high-dose version of Bayer eye drug Eylea
European regulator endorses high-dose version of Bayer eye drug Eylea
Reuters
Bayer
EMA
Eylea
Roche
Flag link:
Bayer CEO Anderson says 'radical realignment' is underway
Bayer CEO Anderson says 'radical realignment' is underway
Fierce Pharma
Bayer
Pharma CEOs
Bill Anderson
layoffs
Flag link:
Bayer adds a new life science incubator in China
Bayer adds a new life science incubator in China
Pharmaphorum
Bayer
Co.Lab
incubators
China
oncology
cell therapy
gene therapy
Flag link:
Bayer doubles down on Factor XIa with new phase 3 trial
Bayer doubles down on Factor XIa with new phase 3 trial
Pharmaphorum
Bayer
clinical trials
asundexian
Factor Xa inhibition
atrial fibrillation
Flag link:
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Fierce Biotech
Novo Nordisk
KBP Biosciences
Bayer
chronic kidney disease
Kerendia
ocedurenone
hypertension
Flag link:
Bayer christens $250M cell therapy 'launch facility' in Berkeley
Bayer christens $250M cell therapy 'launch facility' in Berkeley
Fierce Pharma
Bayer
cell therapy
Berkeley
Californi
BlueRock Therapeutics
Flag link:
Bayer CEO plots management cuts as first step in larger overhaul
Bayer CEO plots management cuts as first step in larger overhaul
Fierce Pharma
Bayer
Pharma CEOs
Bill Anderson
layoffs
Flag link:
Bayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
Bayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
ForbesBayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
Bayer
artificial intelligence
Google
Flag link:
Bayer looks to expand Kerendia label to include heart failure
Bayer looks to expand Kerendia label to include heart failure
Clinical Trials Arena
Bayer
Kerendia
clinical trials
heart failure
Flag link:
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Bayer
cell therapy
Parkinson's Disease
clinical trials
Flag link:
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Bayer
Parkinson's Disease
cell therapy
bemdaneprocel
BlueRock Therapeutics
Flag link:
Bayer's digital drive in consumer health gathers pace
Bayer's digital drive in consumer health gathers pace
Pharmaphorum
Bayer
consumer health
digital health
Mahana Therapeutics
Flag link:
Bayer pledges $500K in drugs and cash relief to Maui following devastating wildfires
Bayer pledges $500K in drugs and cash relief to Maui following devastating wildfires
Fierce Pharma
Bayer
Hawaii
Maui
wildfires
donations
Flag link:
Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts
Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts
Fierce Biotech
BlueRock Therapeutics
Parkinson's Disease
Bayer
layoffs
Flag link:
With sales in free fall, Bayer's new CEO Anderson considers structural change
With sales in free fall, Bayer's new CEO Anderson considers structural change
Fierce Pharma
Bayer
Pharma CEOs
Bill Anderson
Flag link:

Pages